Group 1 - Southbound funds reduced their holdings in HeartCare Medical-B (02160.HK) by 14,000 shares on November 13, 2025 [1] - Over the past 5 trading days, there has been a cumulative net reduction of 192,000 shares by southbound funds [1] - In the last 20 trading days, southbound funds have reduced their holdings for 20 days, totaling a net reduction of 1.733 million shares [1] Group 2 - As of now, southbound funds hold 110 million shares of HeartCare Medical-B, accounting for 4.55% of the company's total issued ordinary shares [1] - The company specializes in providing comprehensive medical solutions for structural heart disease, focusing on transcatheter and surgical solutions [2] - HeartCare Medical's product pipeline includes TAVI series products, AnchorMan left atrial appendage occluder products, transcatheter mitral valve products, transcatheter tricuspid valve products, and surgical support products [2]
心通医疗-B（02160.HK）：11月13日南向资金减持1.4万股